PuSH - Publication Server of Helmholtz Zentrum München

Biswas, S.* ; Rust, L.N.* ; Wettengel, J.M. ; Yusova, S.* ; Fischer, M.* ; Carson, J.N.* ; Johnson, J.* ; Wei, L.* ; Thode, T.* ; Kaadige, M.R.* ; Sharma, S.* ; Agbaria, M.* ; Bimber, B.N.* ; Tu, T.* ; Protzer, U. ; Ploss, A.* ; Smedley, J.V.* ; Golomb, G.* ; Sacha, J.B.* ; Burwitz, B.J.*

Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity.

Nat. Commun. 13:2995 (2022)
Publ. Version/Full Text Research data DOI
Open Access Gold
Creative Commons Lizenzvertrag
Hepatitis B virus has infected a third of the world's population, and 296 million people are living with chronic infection. Chronic infection leads to progressive liver disease, including hepatocellular carcinoma and liver failure, and there remains no reliable curative therapy. These gaps in our understanding are due, in large part, to a paucity of animal models of HBV infection. Here, we show that rhesus macaques regularly clear acute HBV infection, similar to adult humans, but can develop long-term infection if immunosuppressed. Similar to patients, we longitudinally detected HBV DNA, HBV surface antigen, and HBV e antigen in the serum of experimentally infected animals. In addition, we discovered hallmarks of HBV infection in the liver, including RNA transcription, HBV core and HBV surface antigen translation, and covalently closed circular DNA biogenesis. This pre-clinical animal model will serve to accelerate emerging HBV curative therapies into the clinic.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
ISSN (print) / ISBN 2041-1723
e-ISSN 2041-1723
Quellenangaben Volume: 13, Issue: 1, Pages: , Article Number: 2995 Supplement: ,
Publisher Nature Publishing Group
Publishing Place London
Reviewing status Peer reviewed
Grants
ODCDC CDC HHS
NIAID NIH HHS